Sixty two patients diagnosed as having adult chlamydial ophthalmia were treated with oral doxycycline and roxithromycin in association and tetracycline eye wash for 2 weeks. Chlamydial ophthalmia was diagnosed by laboratory detection of the micro-organism in ocular specimens using direct immunofluorescent monoclonal antibody staining for Chiamydia trachomatis, chlamydial culture 
Infections by Chlamydia trachomatis are one of the major causes of venereal diseases in industrialised countries.'2 Adult chlamydial ophthalmia (ACO) usually results from autoinoculation with infected genital secretion" and can be clinically indistinguishable from conjunctivitis and keratoconjunctivitis of bacterial or viral aetiology.5 Clinical features can include a wide range of symptoms from non-specific conjunctival hyperaemia to corneal changes.67 The diagnosis of chlamydial infection is made by the laboratory detection of the micro-organism in ocular specimens. Once diagnosed, ACO should be treated with the appropriate antibiotic therapy. C trachomatis is sensitive to tetracyclines, macrolides (erythromycin, roxithromycin, clarythromycin), rifampicin, sulphonamides, and fluoroquinolones." 9 The Centers for Disease Control have issued treatment guidelines for C trachomatis infections.'0 The tetracyclines are the drugs of first choice, whereas macrolides are recommended for pregnant women, young children, and other patients in whom tetracyclines are contraindicated or not tolerated. Because of the frequent occurrence of concomitant genital infection and the relatively slow replication time of the micro-organism, a systemic antibiotic treatment should be used for 2 weeks.5'0 On its own, topical ocular treatment is usually ineffective; however, it should be given in an attempt to sterilise the ocular secretions more quickly and reduce the risks of transmission of infection. All patients with ACO were treated with oral doxycycline (100 mg daily) and roxithromycin (300 mg daily) in association and tetracycline eye wash (six times daily) for 2 weeks. We recommended patients to inform us promptly about any side effects during the treatment. All ofthem were re-examined and had conjunctival scrapings for detection of C trachomatis by DFA staining 3 weeks after completing their course of antibiotics. In the case of persistent signs and symptoms of infection and positive DFA staining, a further course of the same treatment was given.
Results
Sixty two patients (27 men, 35 women) with ACO participated in the study. Their ages ranged from 16 to 75 years, with an average of 38-9 years. These patients had conjunctivitis or keratoconjunctivitis of duration ranging from 1 month to 12 years; several had been treated unsuccessfully with non-specific topical antibiotics and steroids for a prolonged period. The mean duration of symptoms was about 1 year when a correct diagnosis was secured. The subjective ocular symptoms were discharge, burning, photophobia, sensation of foreign body, itching, tearing, and blurred vision. Clinically, all patients presented with conjunctival hyperaemia associated with papillary and follicular hyperplasia in the palpebral conjunctiva. Corneal lesions observed included fine epithelial punctate keratitis (eight cases), marginal corneal abscesses similar in appearance to those seen in staphylococcal keratoconjunctivitis (six cases), subepithelial punctate infiltrates clinically similar to those associated with adenovirus infection (three cases), and marginal lower micropannus (two cases).
The results of conjunctival scrapings and serological assay are summarised in 
